SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as a report surfaced regarding security flaws in a battlefield communication system, triggering a sharp sell-off despite the company's rebuttal and claims that the issues were resolved. The community is debating the severity and validity of the report, with some viewing it as a buying opportunity while others express concerns about the company's valuation. Discussions also involve the potential impact on government contracts and the trustworthiness of news sources.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amid discussions around Novo Nordisk's potential entry into the telehealth space with an obesity pill, which could impact HIMS' market share, while others are pointing out that weightloss is only a small part of the business. The community is debating whether this news presents a buying opportunity or signals a concerning shift in the competitive landscape, especially since some are looking at the COO exit as a negative catalyst. Some traders are noting technical levels and expressing frustration with the stock's volatile price action and seeming sensitivity to news.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors discuss its potential U.S. expansion and speculate on a possible Nasdaq relisting, with community members pointing to strong fundamentals driving the stock. The company's growth in China, coupled with Starbucks' struggles, is fueling optimism, while others remain cautious due to past accounting issues and the stock's OTC status.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as retail investors and traders discuss its impressive recent gains and potential for future growth within the quantum computing sector. Community members are weighing the possibility of a short squeeze against concerns of overvaluation and a potential offering, while some highlight a recent purchase order announcement. The stock's momentum is drawing attention, with debates swirling around its long-term prospects compared to others in the quantum computing space.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending amid high trading volume and anticipation surrounding potential catalysts, including upcoming airshows and FAA certification progress. The community is actively discussing the possibility of a short squeeze, as well as potential partnerships, with some drawing attention to Tesla's presence in a recent promotional video. Discussions also involve comparisons to sector peer Joby Aviation, with some traders anticipating $ACHR closing the market cap gap.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as investors debate its AI spending and monetization strategies, highlighted by a recent report on AI chatbots exploring ad revenue. Community chatter reflects concerns about its recent price action, with some viewing it as a buying opportunity while others express bearish sentiment. Broader discussions include Meta's competition in the AI and AR spaces, particularly around its smart glasses.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending due to speculation surrounding potential US government investment, fueled by the CEO's confirmation of White House discussions; the community is debating the significance of these talks and comparing USAR to other rare earth companies like MP Materials and LAC. Some investors are concerned about potential dilution from share unlocks and insider selling, while others remain optimistic about USAR's role in securing a domestic rare earth supply chain amid increasing geopolitical tensions.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending amid speculation of a potential buyout, with community members pointing to increased volume and options activity as possible indicators. Chatter suggests that a big tech company could be interested in acquiring the AI firm to bolster its own AI capabilities. Despite recent financial results and leadership changes, the stock is seeing increased interest.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

CLNN is trending as community members discuss the potential for accelerated approval of its ALS treatment following positive commentary from the FDA. Conversations revolve around the company's cash flow, potential offerings, and the possibility of a data leak driving the recent price movement. Some investors express excitement and relief, while others remain cautious due to past experiences and the need for further positive developments.

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Alto Neuroscience Inc.

Alto Neuroscience is trending amid community discussion around a potential short squeeze and recent gains. Some traders cite the company's fundamentals, upcoming data readouts, and potential for a large upside. Others remain cautious, pointing to past trial failures and ongoing discussions about a possible offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

USM's Q2 Earnings Beat Estimates Despite Lower Revenues

USM's earnings beat estimates in the second quarter, with strong momentum in the tower business. Decline in prepaid and postpaid connections hindered growth.

U.S. Cellular (USM) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for U.S. Cellular (USM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

United States Cellular (USM) Surpasses Q2 Earnings and Revenue Estimates

U.S. Cellular (USM) delivered earnings and revenue surprises of +9.09% and +1.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Cogent Communications (CCOI) Reports Q2 Loss, Beats Revenue Estimates

Cogent (CCOI) delivered earnings and revenue surprises of -30.11% and +0.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

U.S. Cellular (USM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Besides Wall Street's top-and-bottom-line estimates for U.S. Cellular (USM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

T-Mobile (TMUS) Q2 Earnings and Revenues Beat Estimates

T-Mobile (TMUS) delivered earnings and revenue surprises of +5.58% and +0.77%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

According to Goldman Sachs Research, a 5% increase in the tariff rate is estimated to reduce S&amp;P 500 earnings per share by 1-2%. The recently considered tariffs have reduced Goldman Sachs' S&amp;P 500 EPS forecasts by roughly 2-3%.&nbsp; Growth stocks are beaten down as recent tariffs triggered a sharp sell-off, with all major indexes, including the Dow Jones Industrial Average (DJI), S&amp;P 500 (SPX), and NASDAQ Composite (IXIC), falling significantly. The impact of US tariffs on the stock market is significant. &nbsp;Historically, the S&amp;P 500 has fallen by 5-7% when the US announced tariffs, as seen in 2018-2019. However, history suggests the downturn was temporary as it caused disruptions, but markets rebounded after the Phase I trade deal. Despite this, like energy, US manufacturers, Biotechnology, and Financials may benefit. As we navigate the current market landscape, let’s take a closer look at 5 stocks across various industries that are not prone to tariff uncertainty and present attractive buying opportunities. Shuttle Pharmaceuticals (SHPH) Shuttle Pharmaceuticals (NASDAQ: SHPH) is a specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy. The company is developing innovative radiation sensitizers, including its lead candidate Ropidoxuridine, to enhance the effectiveness of radiation therapy and bring new treatments to patients with cancer. Phase 2 Clinical Trial for Ropidoxuridine: The company is currently conducting a Phase 2 clinical trial for Ropidoxuridine to treat glioblastoma, a deadly form of brain cancer. The trial is designed to evaluate the safety and efficacy of Ropidoxuridine in combination with radiation therapy. The company has also completed a public offering of $5.75 million to fund its Phase 2 clinical trial, marketing efforts, and general corporate expenses. &nbsp;Expanding its Pipeline: Shuttle Pharmaceuticals is also developing other oncology drug candidates, including SP-2-225 and SP-1-303, which are in the preclinical stages of development. These candidates have the potential to treat a range of cancers, including breast, lung, and prostate cancer. Building Strategic Partnerships: The company is building strategic partnerships with leading cancer centers and research institutions to advance its research and development programs.&nbsp; While Shuttle Pharmaceuticals may not be directly impacted by tariffs, the company may benefit from the Trump administration’s efforts to promote domestic pharmaceutical manufacturing and reduce reliance on foreign imports. The administration is also expected to increase funding for cancer research, which could benefit Shuttle Pharmaceuticals and other companies developing innovative cancer treatments.Kinsale Capital (KNSL) Kinsale Capital (NYSE: KNSL) is a leading excess and surplus lines insurance provider that operates various business segments, including commercial property insurance. The company has a strong presence in the US and is poised for growth, driven by its strategic initiatives and market demand. Expanding Product Lines: Kinsale is continuously expanding its product lines and has recently launched a new agribusiness underwriting unit focused on farm and ranch exposures. Disciplined Underwriting: Kinsale maintains a disciplined approach to underwriting by focusing on high-margin opportunities and managing risks effectively. The company is investing in technology to drive cost efficiencies. Increased Demand: Kinsale’s expanded product lines, strategic underwriting, and focus on high-margin opportunities will drive growth in demand for its insurance products. Strong Financial Metrics: Kinsale has a solid balance sheet, a high cash conversion rate, and a well-diversified investment portfolio that will support its growth and profitability. &nbsp;United States Steel (X) United States Steel (NYSE: X) is a major player in the steel industry, with a strong presence in the United States and a history of innovation and adaptation. The company is expected to benefit from the recent announcement by President Trump to double the tariffs on Canadian steel and aluminum to 50%. Increased Demand and Pricing Power: The company will likely have higher demand, more pricing power, and reduced competition as imports from Canada become more expensive and reduce competition, allowing it to gain market share and increase its revenue. &nbsp;Improving Asset Turnover and Margins: United States Steel is focused on optimizing its operations and improving its asset turnover, with a goal of increasing its return on capital and reducing its costs. Investing in Strategic Projects: United States Steel is investing in new projects, such as the Big River Steel mill, to increase its production capacity and improve its competitiveness. &nbsp;Partnering with Other Companies: The company is exploring partnerships with other companies, such as Nippon Steel, to share technology and expertise and improve its operations. United States Cellular (USM) United States Cellular (NYSE: USM) is a leading telecommunications company providing wireless services to customers across the United States. The company is focusing on expanding its 5G network infrastructure, particularly in rural areas, through partnerships. Upgrading its 5G Network Infrastructure: United States Cellular has partnered with Ericsson to upgrade its 5G network infrastructure in rural areas by leveraging Ericsson’s advanced cell-site router technology to provide efficient transport infrastructure for mid-band spectrum deployment.&nbsp; &nbsp;Monetizing its Spectrum Holdings: United States Cellular has recently made deals to sell select spectrum assets to AT&amp;T and other mobile network operators. The company has agreed to sell a portion of its retained spectrum licenses to AT&amp;T for $1. billion and has also reached definitive deals to monetize around 70% of its total spectrum holdings (excluding mmWave). Financial Performance and Guidance: The company reported Q4 non-GAAP EPS of $0.05 and revenue of $970 million, which beat estimates by $5.3 million. Spectrum Portfolio And Future Plans: After the proposed sales, UScellular will be left with 1.86 billion MHz-Pops of low and mid-band spectrum, as well as 17.2 billion MHz-Pops of mmWave spectrum, with the substantial majority of retained value in the C-band spectrum. Plains GP (PAGP) Plains GP (NASDAQ: PAGP) is a midstream oil and gas company with diversified operations, primarily in crude oil. The company also owns an indirect, non-economic controlling interest in Plains All American Pipeline, a Master Limited Partnership focused on oil and gas midstream operations. Expanding its Asset Base Through Bolt-On Acquisitions: Plains GP has recently completed several acquisitions, including the Ironwood Midstream Energy acquisition and the purchase of the remaining 50% interest in Midway Pipeline, to strengthen its integrated asset base. &nbsp;Increasing Quarterly Distribution: The company has announced a 20% increase in its quarterly distribution, bringing the annualized distribution to $1.52 per unit, and plans to continue increasing the dividend by at least $0.15 per year with a 160% coverage. Investing in Growth Capital Expenditure: Plains GP plans to invest around $400 million annually in growth capex, including investments in Permian JV improvements to drive growth and increase earnings. Optimizing its Assets and Operations: The company is focused on optimizing its assets and operations, including increasing utilization of Corpus Christi-bound assets and growing Permian crude production to drive growth and increase efficiency. &nbsp;Conclusion While all the companies discussed present strong growth potential, Shuttle Pharmaceuticals stands out as a unique investment opportunity. As a US-based company with a domestic supply chain, it is insulated from trade-related disruptions. Moreover, its cutting-edge approach to cancer treatment, ongoing clinical trials, and strategic partnerships position it for substantial growth in the biotech sector.&nbsp; Read Next: Why This Electric Vehicle Market Player’s Proprietary Battery-Swapping Technology is a Game-Changer Our email list eats first! Get exclusive alerts on explosive stock picks like AST SpaceMobile (NASDAQ: ASTS), which shot up +533% after our profile. Get our email signals based on our proprietary 5-indicator system before any of our other platforms by clicking here. Join the Discussion in the WVC Facebook Investor Group Do you have a stock tip or news story suggestion? Please email us at Invest@WealthyVC.com. &nbsp;This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. Wealthy VC and its employees are not Registered Investment Advisors, Broker-Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Wealthy VC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and Wealthy VC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Our website and newsletter are for entertainment purposes only. This website is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. &nbsp;Release of Liability: Through the use of this email and/or website advertisement, by viewing or using it, you agree to hold Wealthy VC, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Wealthy VC-sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by Wealthy VC or an offer or solicitation to buy or sell any security. WealthyVC and our controlling entity 1000724287 Ontario Ltd have been compensated USD $7,500 per month for six months for investor relations by Shuttle Pharmaceuticals Holdings, Inc. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provided herein. Instead, Wealthy VC strongly urges you to conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D and all reports published on SEDAR if the company featured is Canadian. Wealthy VC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled. The Private Securities Litigation Reform Act of 1995 provides investors with a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements”. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day’s closing price and the high of-day price during our promotional coverage. In preparing this publication, Wealthy VC has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, Wealthy VC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of material facts from such advertisement. Wealthy VC is not responsible for any claims made by the companies advertised herein, nor is Wealthy VC responsible for any other promotional firm, its program or its structure. <a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/disclaimer/">View Full Disclaimer</a>&nbsp;

In this photo illustration, the Kinsale Capital Group logo is displayed on a smartphone screen

Growth Stocks Are Beaten Down. Why It’s Temporary and What Should Be On Your Shopping List Instead

According to Goldman Sachs Research, a 5% increase in the tariff rate is estimated to reduce S&P 500 earnings per share by 1%-2%

Others

UScellular reports fourth quarter and full year 2024 results

UScellular reports fourth quarter and full year 2024 results UScellular reports fourth quarter and full year 2024 results PR Newswire CHICAGO, Feb. 21, 2025 As previously announced, UScellular will...

TDS and UScellular to release fourth quarter operating results and host conference call on February 21, 2025

TDS and UScellular to release fourth quarter operating results and host conference call on February 21, 2025 TDS and UScellular to release fourth quarter operating results and host conference call on...

TDS announces CEO transition

TDS announces CEO transition TDS announces CEO transition PR Newswire CHICAGO, Jan. 27, 2025 TDS Board Chair Walter C. D. Carlson appointed President and CEO LeRoy T. Carlson, Jr.to become Vice Chair...

Array Digital Infrastructure, Inc. engages in the provision of wireless telecommunication services. It operates through the Wireless and Towers segments. The Wireless segment uses company-owned towers to locate its network equipment, using estimated market pricing. The Towers segment records rental revenue. The firm’s products include smartphones, tablets, vehicle routers, and accessories. It offers Internet plans, prepaid & postpaid plans, and roaming services. The company was founded by Leroy T. Carlson in 1983 and is headquartered in Chicago, IL.

Array Digital Infrastructure Inc.

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.25	--	--	N/A
Q2 '25	$0.29	$0.36	22.03%	BEAT
Q1 '25	$0.31	$0.21	-31.15%	MISSED
Q4 '24	-$0.03	$0.05	300.00%	BEAT
Q3 '24	$0.12	-$0.92	-866.67%	MISSED

USM
United States Cellular Corporation

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest USM News

USM United States Cellular Corporation